1. Atezolizumab/durvalumab/pembrolizumab

   Case report 01 October 2022 Pages: 101 - 101

2. Atropine/baclofen/gabapentin

   Case report 01 October 2022 Pages: 102 - 102

3. Avelumab

   Case report 01 October 2022 Pages: 103 - 103

4. Azathioprine/corticosteroids/mesalazine

   Case report 01 October 2022 Pages: 104 - 104

5. Azathioprine/mesalazine

   Case report 01 October 2022 Pages: 105 - 105

6. Azathioprine/montelukast/prednisone

   Case report 01 October 2022 Pages: 106 - 106

7. Azathioprine/prednisolone

   Case report 01 October 2022 Pages: 107 - 107

8. Azathioprine/prednisone

   Case report 01 October 2022 Pages: 108 - 108

9. Azathioprine/prednisone/terbinafine

   Case report 01 October 2022 Pages: 109 - 109

10. AZD 1222

    Case report 01 October 2022 Pages: 110 - 110

11. AZD-1222

    Case report 01 October 2022 Pages: 111 - 111

12. AZD-1222

    Case report 01 October 2022 Pages: 112 - 112

13. AZD-1222

    Case report 01 October 2022 Pages: 113 - 113

14. AZD-1222

    Case report 01 October 2022 Pages: 114 - 114

15. AZD-1222

    Case report 01 October 2022 Pages: 115 - 115

16. AZD-1222

    Case report 01 October 2022 Pages: 116 - 116

17. AZD-1222/immune-globulin

    Case report 01 October 2022 Pages: 117 - 117

18. Azd-1222/tozinameran

    Case report 01 October 2022 Pages: 118 - 118

19. Azithromycin/benzathine benzylpenicillin/metronidazole

    Case report 01 October 2022 Pages: 119 - 119

20. Baclofen/omeprazole

    Case report 01 October 2022 Pages: 120 - 120

21. Baclofen/tramadol

    Case report 01 October 2022 Pages: 121 - 121

22. Baricitinib/hydroxychloroquine/prednisolone

    Case report 01 October 2022 Pages: 122 - 122

23. Basiliximab/ruxolitinib/vedolizumab

    Case report 01 October 2022 Pages: 123 - 123

24. BBIBP-CorV

    Case report 01 October 2022 Pages: 124 - 124

25. Bbibp-corv/tozinameran

    Case report 01 October 2022 Pages: 125 - 125

26. BBV-152

    Case report 01 October 2022 Pages: 126 - 126

27. BCG

    Case report 01 October 2022 Pages: 127 - 127

28. Belatacept

    Case report 01 October 2022 Pages: 128 - 128

29. Bendamustine/tisagenlecleucel

    Case report 01 October 2022 Pages: 129 - 129

30. Benralizumab

    Case report 01 October 2022 Pages: 130 - 130

31. Benzocaine

    Case report 01 October 2022 Pages: 131 - 131

32. Bevacizumab

    Case report 01 October 2022 Pages: 132 - 132

33. Bevacizumab

    Case report 01 October 2022 Pages: 133 - 133

34. Bevacizumab/endostatin/rivoceranib

    Case report 01 October 2022 Pages: 134 - 134

35. Bevacizumab/lobaplatin/paclitaxel

    Case report 01 October 2022 Pages: 135 - 135

36. Bicalutamide/exemestane/leuprorelin

    Case report 01 October 2022 Pages: 136 - 136

37. Bortezomib/immunosuppressants/rituximab

    Case report 01 October 2022 Pages: 137 - 137

38. Brolucizumab

    Case report 01 October 2022 Pages: 138 - 138

39. Bulevirtide

    Case report 01 October 2022 Pages: 139 - 139

40. Bupivacaine

    Case report 01 October 2022 Pages: 140 - 140

41. Bupivacaine/carbamazepine/dexamethasone

    Case report 01 October 2022 Pages: 141 - 141

42. Bupropion/olanzapine

    Case report 01 October 2022 Pages: 142 - 142

43. Cabergoline

    Case report 01 October 2022 Pages: 143 - 143

44. Cabozantinib/selpercatinib/vandetanib

    Case report 01 October 2022 Pages: 144 - 144

45. Cade oil

    Case report 01 October 2022 Pages: 145 - 145

46. Camrelizumab

    Case report 01 October 2022 Pages: 146 - 146

47. Camrelizumab/pembrolizumab

    Case report 01 October 2022 Pages: 147 - 147

48. Cannabidiol/immunosuppressants

    Case report 01 October 2022 Pages: 148 - 148

49. Carbamazepine

    Case report 01 October 2022 Pages: 149 - 149

50. Carboplatin/dexamethasone/paclitaxel

    Case report 01 October 2022 Pages: 150 - 150